1. India Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
Natural Biocon (India) Ltd.

Natural Biocon (India) Ltd.

BBSE:NATURAL
1.91
INR
-0.05
(-2.55%)
-0.08EPS
96.69MMarket Cap
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.02
0.05
0.14
0.92
0.39
- -
0.12
0.42
1.1
11.9
3.74
1.27
0.38
Basic EPS, GAAP
- -
- -
0.07
0.62
0.06
-0.07
- -
0.06
0.16
0.13
0.02
-0.02
-0.08
Free Cash Flow per Basic Share
0.02
0.04
0.19
-0.03
-0.76
0.13
0.29
0.17
0.19
-0.11
0.13
0.01
- -
Dividend per Share
- -
- -
0.05
0.05
0.05
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
10
10
10
10.56
10.56
10.54
10.54
10.59
10.75
10.89
12.36
11.92
- -
Tangible Book Value per Share
10
10
10
10.56
10.56
10.54
10.54
10.59
10.75
10.89
12.36
11.92
- -
Basic Weighted Avg Shares
11
11
11
11
11
11
11
11
11
11
22
20
23
Sales/Revenue/Turnover
- -
1
2
10
4
- -
1
5
13
135
83
25
9
Operating Margin (%)
-3.68
-1.22
70.68
95.96
24.95
- -
3.23
18.41
19.79
1.67
0.71
-1.62
-21.92
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
1
7
1
-1
- -
1
2
2
- -
- -
-2
Effective Tax Rate (%)
- -
- -
30
29.98
39.98
- -
25
25.03
27.5
32.24
25.17
- -
- -
Profit Margin (%)
-3.68
-1.22
49.48
67.19
16.17
- -
2.08
13.68
14.28
1.13
0.53
-1.57
-21.79
Working Capital
11
12
12
18
9
12
14
7
9
20
4
-9
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
114
114
114
120
120
120
120
121
122
124
319
307
- -
Return on Invested Capital (%)
- -
- -
0.67
5.99
0.54
- -
0.03
0.54
1.45
1.22
0.2
- -
- -
Return on Capital (%)
- -
- -
0.67
5.99
0.58
- -
0.02
0.54
1.46
1.23
0.2
- -
- -
Return on Common Equity (%)
- -
-0.01
0.67
5.99
0.6
-0.67
0.02
0.55
1.48
1.24
0.2
-0.13
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
4
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
26
26
26
Market Capitalization
114
84
97

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
52
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
51
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
61
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
4
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
16.25%
31.42%
-3.57%
Free Cash Flow
170.28%
-123.59%
-90.17%
Net Income, GAAP
-965.43%
438.65%
-189.69%
Sales/Revenue/Turnover
- -
259.34%
-69.52%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
10
47
13
14
83
2026
17
- -
- -
9
25
2027
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.09
0.08
0.1
-0.19
0.02
2026
0.05
-0.02
-0.02
-0.04
-0.02
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Arunkumar D. Prajapati
Full Time Employees
3
Sector
Process industries
Industry
Chemicals: specialty
Address
1007, Sankalp Iconic Ahmedabad GU India 380054
IPO Date
May 19, 2020
Website
naturalbiocon.com
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
PI Industries Limited (NSE:PIIND)
Business
Natural Biocon (India) Limited Natural Biocon (India) Limited (NSE: NATURAL.BO) engages in the extraction, procurement, crushing, separation, trading, and dealing of plants, seeds, agricultural produce, vegetation, juices, and alkaloids including nicotine, caffeine, tannin, morphine, codeine, strychnine, nuxvomica, and brucine; it manufactures agrochemicals, barley malt, maltose, malt sugar, and derivatives thereof. The company trades chemicals, natural extracts, and agricultural commodities, with a focus on natural food colors derived from Bixa orellana such as Norbixin, positioning these as healthier alternatives to synthetic colors restricted or banned in various countries due to health risks. Operations center in Gujarat, India, targeting related industries domestically through retail trading channels. Incorporated on August 27, 1992, as a public limited company in Gujarat, Natural Biocon (India) Limited maintains its headquarters in Ahmedabad at A-1007, Sankalp Iconic Tower, opposite Vikram Nagar, Iscon Temple Cross Road. Initially a pioneer in natural color manufacturing using modern technology, the company has shifted emphasis to chemical and agricultural produce trading in select Gujarat regions amid eroding export monopolies in traditional commodities like tobacco and rising demand for fruits, vegetables, and rice. It anticipates further ventures into agriculture produce, marine products, solar energy, and infrastructure, subject to statutory approvals. Recent developments include the launch of a Norbixin production project with 180 tonnes per annum capacity, backed by a Rs 1.80 crore nucleus farm to support sustainable natural food color output; the company financed expansion by issuing 7.63 crore equity shares, increasing paid-up capital to Rs 25.78 crore as of March 2025. Equity capital doubled from prior levels, enabling investments reaching Rs 21.12 crore, while maintaining near debt-free status and reducing working capital days to 14.9 from 66.1. In 2025, it conducted its 33rd annual general meeting on September 30, reappointing management and auditors amid 20.22% shareholder turnout.